|
Univariate analysis |
Multivariate analysis |
|
|
|
|
|
HR |
95% CI |
P value |
HR |
95% CI |
P
value |
Age(years) |
|
|
|
|
|
|
(≤60 vs.>60) |
1.006 |
0.610-1.659 |
0.981 |
|
|
|
Gender |
|
|
|
|
|
|
(Female vs.Male) |
0.933 |
0.541-1.609 |
0.802 |
|
|
|
Tumor location |
|
|
|
|
|
|
(Left colon vs.Right colon) |
1.004 |
0.602-1.676 |
0.987 |
|
|
|
MMR |
|
|
|
|
|
|
(pMMR vs.dMMR) |
0.483 |
0.237-0.988 |
0.046 |
0.447 |
0.196-1.019 |
0.055 |
KRAS |
|
|
|
|
|
|
(KRAS mutant vs.KRAS wild) |
0.783 |
0.463-1.323 |
0.360 |
|
|
|
Combined with targeted therapy |
|
|
|
|
|
|
(No vs.Yes) |
1.223 |
0.731-2.048 |
0.443 |
|
|
|
Liver metastases |
|
|
|
|
|
|
(No vs.Yes) |
1.412 |
0.774-2.576 |
0.261 |
|
|
|
Lymph nodes metastases |
|
|
|
|
|
|
(No vs.Yes) |
0.930 |
0.531-1.629 |
0.800 |
|
|
|
ICI |
|
|
|
|
|
|
(Domestic vs.Imported) |
1.496 |
0.774-2.890 |
0.231 |
|
|
|
NLR |
|
|
|
|
|
|
(<3 vs.≥3) |
1.944 |
1.155-3.272 |
0.012 |
1.918 |
1.088-3.382 |
0.024 |